3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Breast Neoplasms
4
Lung Neoplasms
3
Colorectal Neoplasms
3
Uterine Cervical Neoplasms
2
Sleep Initiation and Maintenance Disorders
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Melanoma
2
Depression
2
Anxiety Disorders
2
Uterine Neoplasms
1
Smoking Cessation
1
Sleep Wake Disorders
1
Pancreatic Neoplasms
1
Pain
1
Multiple Myeloma
1
Lymphoma
1
Leukemia
1
Hepatitis B
1
Glioblastoma
1
Genetic Predisposition to Disease
1
Gastrointestinal Neoplasms
1
Gallstones
1
Fatigue
1
Fanconi Anemia, Complementation Group D1
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Hepatocellular
1
Interventions
Oxaliplatin
29
Fluorouracil
25
Leucovorin
20
Capecitabine
18
Irinotecan
17
Surveys and Questionnaires
16
Bevacizumab
14
Cisplatin
12
Blood Specimen Collection
11
Drug Therapy
10
Standard of Care
9
Nivolumab
9
Gemcitabine
9
Cetuximab
7
pembrolizumab
6
Specimen Handling
6
S 1 (combination)
6
Endoscopic Mucosal Resection
6
Cyclophosphamide
6
atezolizumab
5
Sunitinib
5
Radiotherapy
5
Folfox protocol
5
Educational Status
5
Docetaxel
5
fludarabine
4
aldesleukin
4
Radiosurgery
4
Pemetrexed
4
Magnetic Resonance Spectroscopy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
Cognitive Behavioral Therapy
×
Gastrointestinal
×
Clear all
NCT04899492
2024-11-07
RESPIRE
Institut Cancerologie de l'Ouest
Phase NA
Terminated
22 enrolled